Iclusig

ponatinib · Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

58 regulatory and trial events tracked for Iclusig, covering 2012-12-14 to 2026-07-31. Get the full timeline:

Most recent: EMA Authorised: Iclusig (ponatinib) — Incyte Biosciences Distribution B.V.